NCT04346264View on ClinicalTrials.gov

CoVid-19 - Infection and Antibody Formation in the Viennese Population

CompletedOBSERVATIONAL
Enrollment

12,419

Participants

Timeline

Start Date

April 27, 2020

Primary Completion Date

May 27, 2020

Study Completion Date

May 27, 2020

Conditions
Virus DiseasesCOVID-19
Interventions
DIAGNOSTIC_TEST

NO intervention planned due to the observational study design only a diagnostic testing

Only a diagnostic test (serum blood and antibody measurement) is planned

Trial Locations (1)

1140

The LEAD Study Center, Vienna

All Listed Sponsors
lead

Ludwig Boltzmann Institute for Lung Health

OTHER

NCT04346264 - CoVid-19 - Infection and Antibody Formation in the Viennese Population | Biotech Hunter | Biotech Hunter